These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35540174)

  • 1. Rational design, preparation and characterization of recombinant Ag85B variants and their glycoconjugates with T-cell antigenic activity against
    Rinaldi F; Tengattini S; Piubelli L; Bernardini R; Mangione F; Bavaro T; Paone G; Mattei M; Pollegioni L; Filice G; Temporini C; Terreni M
    RSC Adv; 2018 Jun; 8(41):23171-23180. PubMed ID: 35540174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of glycosylation on the affinity of the MTB protein Ag85B for specific antibodies: towards the design of a dual-acting vaccine against tuberculosis.
    Bernardini R; Tengattini S; Li Z; Piubelli L; Bavaro T; Modolea AB; Mattei M; Conti P; Marini S; Zhang Y; Pollegioni L; Temporini C; Terreni M
    Biol Direct; 2024 Jan; 19(1):11. PubMed ID: 38268026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycosylation of Recombinant Antigenic Proteins from Mycobacterium tuberculosis: In Silico Prediction of Protein Epitopes and Ex Vivo Biological Evaluation of New Semi-Synthetic Glycoconjugates.
    Bavaro T; Tengattini S; Piubelli L; Mangione F; Bernardini R; Monzillo V; Calarota S; Marone P; Amicosante M; Pollegioni L; Temporini C; Terreni M
    Molecules; 2017 Jun; 22(7):. PubMed ID: 28661444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitope and affinity determination of recombinant Mycobacterium tuberculosis Ag85B antigen towards anti-Ag85 antibodies using proteolytic affinity-mass spectrometry and biosensor analysis.
    Rinaldi F; Lupu L; Rusche H; Kukačka Z; Tengattini S; Bernardini R; Piubelli L; Bavaro T; Maeser S; Pollegioni L; Calleri E; Przybylski M; Temporini C
    Anal Bioanal Chem; 2019 Jan; 411(2):439-448. PubMed ID: 30498982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid chromatography-mass spectrometry structural characterization of neo glycoproteins aiding the rational design and synthesis of a novel glycovaccine for protection against tuberculosis.
    Temporini C; Bavaro T; Tengattini S; Serra I; Marrubini G; Calleri E; Fasanella F; Piubelli L; Marinelli F; Pollegioni L; Speranza G; Massolini G; Terreni M
    J Chromatogr A; 2014 Nov; 1367():57-67. PubMed ID: 25282312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly (lactide-co-glycolide) microspheres in respirable sizes enhance an in vitro T cell response to recombinant Mycobacterium tuberculosis antigen 85B.
    Lu D; Garcia-Contreras L; Xu D; Kurtz SL; Liu J; Braunstein M; McMurray DN; Hickey AJ
    Pharm Res; 2007 Oct; 24(10):1834-43. PubMed ID: 17657598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycovaccine Design: Optimization of Model and Antitubercular Carrier Glycosylation via Disuccinimidyl Homobifunctional Linker.
    Tengattini S; Rubes D; Serra M; Piubelli L; Pollegioni L; Calleri E; Bavaro T; Massolini G; Terreni M; Temporini C
    Pharmaceutics; 2023 Apr; 15(5):. PubMed ID: 37242563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA vaccine with discontinuous T-cell epitope insertions into HSP65 scaffold as a potential means to improve immunogenicity of multi-epitope Mycobacterium tuberculosis vaccine.
    Wu M; Li M; Yue Y; Xu W
    Microbiol Immunol; 2016 Sep; 60(9):634-45. PubMed ID: 27531823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity and protective efficacy of a fusion protein vaccine consisting of antigen Ag85B and HspX against Mycobacterium tuberculosis infection in mice.
    Li Q; Yu H; Zhang Y; Wang B; Jiang W; Da Z; Xian Q; Wang Y; Liu X; Zhu B
    Scand J Immunol; 2011 Jun; 73(6):568-76. PubMed ID: 21323695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of epitope recognition pattern in Ag85B and ESAT-6 has a profound influence on vaccine-induced protection against Mycobacterium tuberculosis.
    Bennekov T; Dietrich J; Rosenkrands I; Stryhn A; Doherty TM; Andersen P
    Eur J Immunol; 2006 Dec; 36(12):3346-55. PubMed ID: 17109467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and humoral immunogenicity of recombinant Mycobacterium smegmatis expressing Ag85B epitopes in mice.
    Kadir NA; Sarmiento ME; Acosta A; Norazmi MN
    Int J Mycobacteriol; 2016 Mar; 5(1):7-13. PubMed ID: 26927984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of recombinant bacille Calmette-Guérin vaccine secreting interleukin-15/antigen 85B fusion protein in providing protection against Mycobacterium tuberculosis.
    Tang C; Yamada H; Shibata K; Maeda N; Yoshida S; Wajjwalku W; Ohara N; Yamada T; Kinoshita T; Yoshikai Y
    J Infect Dis; 2008 May; 197(9):1263-74. PubMed ID: 18422438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoenzymatic synthesis of arabinomannan (AM) glycoconjugates as potential vaccines for tuberculosis.
    Li Z; Bavaro T; Tengattini S; Bernardini R; Mattei M; Annunziata F; Cole RB; Zheng C; Sollogoub M; Tamborini L; Terreni M; Zhang Y
    Eur J Med Chem; 2020 Oct; 204():112578. PubMed ID: 32717482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and efficacy analyses of EPC002, ECA006, and EPCP009 protein subunit combinations as tuberculosis vaccine candidates.
    Wang R; Fan X; Jiang Y; Li G; Li M; Zhao X; Luan X; Deng Y; Chen Z; Liu H; Wan K
    Vaccine; 2023 Jun; 41(26):3836-3846. PubMed ID: 37225573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene-based neonatal immune priming potentiates a mucosal adenoviral vaccine encoding mycobacterial Ag85B.
    Dai G; Rady HF; Huang W; Shellito JE; Mason C; Ramsay AJ
    Vaccine; 2016 Dec; 34(50):6267-6275. PubMed ID: 27823900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Construction and immunogenicity of DNA vaccine encoding secreted form of Ag85B protein of Mycobacterium tuberculosis].
    Fan X; Xu Z; Li Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Sep; 24(9):548-50. PubMed ID: 11758171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteome Profile Changes Induced by Heterologous Overexpression of
    García-Ruiz V; Orduña P; Castillo-Rodal AI; Flores-Rodríguez TJ; López-Vidal Y
    Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational design of multiple TB antigens TB10.4 and TB10.4-Ag85B as subunit vaccine candidates against Mycobacterium tuberculosis.
    Shi S; Yu L; Sun D; Liu J; Hickey AJ
    Pharm Res; 2010 Feb; 27(2):224-34. PubMed ID: 19862606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and HLA restriction of naturally derived Th1-cell epitopes from the secreted Mycobacterium tuberculosis antigen 85B recognized by antigen-specific human CD4(+) T-cell lines.
    Mustafa AS; Shaban FA; Abal AT; Al-Attiyah R; Wiker HG; Lundin KE; Oftung F; Huygen K
    Infect Immun; 2000 Jul; 68(7):3933-40. PubMed ID: 10858206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hijacking bacterial glycosylation for the production of glycoconjugates, from vaccines to humanised glycoproteins.
    Cuccui J; Wren B
    J Pharm Pharmacol; 2015 Mar; 67(3):338-50. PubMed ID: 25244672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.